Additionally, AXL can be cleaved by the A disintegrin and metalloproteinases (ADAM) 10 and ADAM17 to generate soluble AXL (sAXL), which inhibit AXL function and could be a promising biomarker for predicting cancer progression [47]. Here, AXL is linked to cancer.